Company Filing History:
Years Active: 1981-1985
Title: Ulf P Lindahl: A Pioneer in Anticoagulation Innovations
Introduction
Ulf P Lindahl is a distinguished inventor based in Uppsala, Sweden. He has made significant contributions to the field of anticoagulation through his innovative research and inventions, holding two notable patents. His work not only showcases his dedication to advancing medical science but also highlights the importance of oligosaccharides in therapeutic applications.
Latest Patents
Ulf P Lindahl's groundbreaking patents focus on the development of oligosaccharides that possess selective anticoagulation activity. His first patent describes an oligosaccharide containing 4-8 monosaccharide units, characterized by at least one glucosamine unit that is 3-O-sulfated, along with an additional glucosamine unit linked through an intermediate monosaccharide unit. This invention is crucial for creating pharmaceutical compositions that utilize these specialized oligosaccharides.
Additionally, his second patent addresses heparin fragments with selective anticoagulation activity, comprising 14-18 sugar units. Notably, the main component is a disaccharide unit known as L-iduronosyl-2-O-sulphate-N-sulpho-U-glucosamine-6-O-sulphate, with unsulphated L-iduronic acid positioned 3-5 sugar units from the unreducing terminal. This patent also includes the formulation of pharmaceutical compositions containing these heparin fragments and outlines the processes for their preparation.
Career Highlights
Throughout his career, Ulf P Lindahl has been associated with prominent companies, including Kabi AB and Kabivitrum AB. His experience and expertise in the pharmaceutical sector have significantly advanced the understanding and development of anticoagulant therapies. His innovative work continues to impact the medical community and improve patient outcomes.
Collaborations
Ulf has collaborated with notable professionals in the field, including Gudrun E Backstrom and John Y Thunberg. These collaborations have fostered a rich exchange of ideas and furthered the development of his impactful inventions in medical science.
Conclusion
Ulf P Lindahl's contributions to the field of anticoagulation through his patents on oligosaccharides and heparin fragments demonstrate his commitment to innovation. His work not only enhances pharmaceutical compositions but also opens new avenues for research and therapeutic applications. As a dedicated inventor, Lindahl's legacy will undoubtedly continue to influence future advancements in the medical field.